Anhui Honglu Steel Construction (002541.SZ) subsidiary signs major business contract, with an estimated contract value of approximately 280 million yuan.
Honglu Steel Construction (002541.SZ) announced that its wholly-owned subsidiary, Anhui Hongxiang Building Materials Co., Ltd., signed a "*** Production Line Project Memorandum" with China Construction First Building (Group) Corporation Limited, Beijing Baihui Yixiang Science and Trade Co., Ltd., and Anhui Kunzhicheng Steel Structure Co., Ltd. The estimated contract value is approximately 280 million yuan, accounting for about 1.27% of the company's audited main business revenue for 2025.
Anhui Honglu Steel Construction (002541.SZ) announced that its wholly-owned subsidiary, Anhui Hongxiang Building Materials Co., Ltd., signed a "*** Production Line Project Memorandum" with China Construction First Building (Group) Construction & Development Co., Ltd., Beijing Baihui Yixiang Science and Trade Co., Ltd., and Anhui Kunzhicheng Steel Structure Co., Ltd. The estimated contract value is approximately 280 million yuan, accounting for about 1.27% of the company's audited main business revenue for 2025.
Related Articles
Beijing Huayuan Xinhang Holding (600743.SH)'s controlling shareholder is proposed to be changed to Financial Street Holdings Capital.
Shenzhen Techwinsemi Technology (001309.SZ)'s application for additional stock issuance has been approved by the Listing Review Center of the Shenzhen Stock Exchange.
Beijing Beilu Pharmaceutical (300016.SZ) obtained the drug registration certificate for Bimatoprost Eye Drops.
Beijing Huayuan Xinhang Holding (600743.SH)'s controlling shareholder is proposed to be changed to Financial Street Holdings Capital.
Shenzhen Techwinsemi Technology (001309.SZ)'s application for additional stock issuance has been approved by the Listing Review Center of the Shenzhen Stock Exchange.
Beijing Beilu Pharmaceutical (300016.SZ) obtained the drug registration certificate for Bimatoprost Eye Drops.
RECOMMEND
